BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2025506)

  • 1. Imaging of central nervous system tumors.
    Dillon WP
    Curr Opin Radiol; 1991 Feb; 3(1):46-50. PubMed ID: 2025506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
    Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
    Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N
    Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast enhanced fast fluid-attenuated inversion-recovery MR imaging for diagnosing cerebral venous angioma: report of two cases].
    Yamasaki F; Kurisu K; Arita K; Yamanaka M; Ohba S; Hanaya R; Shibukawa M; Kiura Y; Sakamoto S; Okazaki T; Takaba J; Abe N
    No To Shinkei; 2003 Jun; 55(6):537-41. PubMed ID: 12884808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of magnetic resonance imaging in differentiating compartmental location of spinal tumors.
    Khanna AJ; Shindle MK; Wasserman BA; Gokaslan ZL; Gonzales RA; Buchowski JM; Riley LH
    Am J Orthop (Belle Mead NJ); 2005 Oct; 34(10):472-6. PubMed ID: 16304794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the spine and spinal cord.
    Manelfe C
    Curr Opin Radiol; 1991 Feb; 3(1):5-15. PubMed ID: 2025507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.
    Roberts HC; Roberts TP; Bollen AW; Ley S; Brasch RC; Dillon WP
    Acad Radiol; 2001 May; 8(5):384-91. PubMed ID: 11345268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast enhancement in primary tumors of the brain and spinal cord.
    Castillo M
    Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging evaluation of seizures.
    Bradley WG; Shey RB
    Radiology; 2000 Mar; 214(3):651-6. PubMed ID: 10715025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of adult intra-axial brain tumors.
    Lewin JS; Estes ML; Ross JS
    Top Magn Reson Imaging; 1992 Sep; 4(4):17-40. PubMed ID: 1419032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of pediatric and congenital brain disease.
    Kendall BE; Demaerel P
    Curr Opin Radiol; 1992 Feb; 4(1):28-37. PubMed ID: 1739598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.